Search results for " Replacement"

showing 10 items of 539 documents

Incidence of heterotopic ossification in minimally invasive short-stem THA using the modified anterolateral approach.

2017

Introduction Heterotopic ossification (HO) is known to be a common complication after total hip arthroplasty (THA). The minimal invasive (MIS) modified anterolateral approach has become popular in combination with a short stem. We analysed the incidence of HO following short-stem THA using this approach in combination with a postoperative administration of nonsteroidal anti-inflammatory drugs (NSAIDs). Materials and methods 216 short stems were implanted in 162 patients. NSAIDs were administered for 2 weeks after surgery in 154 patients (95.1%). Standardised pre- and postoperative radiographic imaging was done at 2-year follow-up. HO was analysed according to the Brooker classification. Inf…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentArthroplasty Replacement HipOsteoarthritisProsthesis DesignRisk AssessmentOsteoarthritis HipBody Mass IndexCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsmedicineHumansMinimally Invasive Surgical ProceduresOrthopedics and Sports Medicine030212 general & internal medicineAgedPain MeasurementRetrospective StudiesHip surgeryPostoperative Care030222 orthopedicsShort stemOssificationbusiness.industryIncidence (epidemiology)IncidenceOssification HeterotopicAnti-Inflammatory Agents Non-SteroidalAge FactorsRecovery of FunctionMiddle Agedmedicine.diseaseArthroplastySurgeryPatient SatisfactionSurgeryHeterotopic ossificationFemaleHip Prosthesismedicine.symptombusinessComplicationHip international : the journal of clinical and experimental research on hip pathology and therapy
researchProduct

Assessment of successful valve reconstruction by intraoperative transesophageal echocardiography (TEE)

1986

In 17 patients (10 patients with mitral insufficiency, 5 patients with tricuspid regurgitation, 2 patients with mitral stenosis) the result of valve reconstruction was evaluated by intraoperative two-dimensional transesophageal contrast-echocardiography (TEE). Therefore, 1–2 cc of an agitated contrast-medium (GelifundolR) were injected into the left or right ventricle. The result of reconstruction was assessed by the extent of regurgitant microbubbles into the left or right atrium. A successful valve repair could be demonstrated in 15 patients without or with only minimal regurgitation of contrast-fluid. In one patient residual severe mitral insufficiency after valve reconstruction could on…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRegurgitation (circulation)Intraoperative PeriodEsophagusValve replacementInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingHeart valveCardiac imagingAgedbusiness.industryMiddle Agedmedicine.diseaseHeart ValvesSurgeryStenosismedicine.anatomical_structureEchocardiographyVentricleMitral incompetencecardiovascular systemCardiologyFemaleIntraoperative PeriodCardiology and Cardiovascular MedicinebusinessThe International Journal of Cardiac Imaging
researchProduct

Vitamin D serum levels in multiorgan failure critically ill patients undergoing continuous renal replacement therapies

2020

Introduction Severe vitamin D deficiency in critically ill patients is linked to mortality. There are no scientific data regarding vitamin D status in critically ill patients undergoing continuous renal replacement therapies. Material and methods We aimed to measure vitamin D serum levels in critically ill patients with multi-organ failure undergoing continuous renal replacement therapies. Vitamin D serum measurements in 12-hour time intervals were performed in 20 patients undergoing continuous renal replacement therapies through continuous veno-venous haemodiafiltration (the study group). The results were then compared with the historical control group (20 patients without renal replacemen…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentcontinuous renal replacement therapyvitamin DCritical Care and Intensive Care MedicineSeverity of Illness IndexGastroenterologyvitamin D deficiencyAnesthesiologyInternal medicineIntensive caremedicineVitamin D and neurologyHumanscritical illnessRD78.3-87.3Renal replacement therapycritical illness.intensive careRC86-88.9Critically illbusiness.industryAcute kidney injuryMedical emergencies. Critical care. Intensive care. First aidGeneral MedicineMiddle AgedVitamin D Deficiencymedicine.diseaseMultiorgan failureAnesthesiology and Pain Medicineacute kidney injuryCase-Control StudiesCritical illnessbusinessAnaesthesiology Intensive Therapy
researchProduct

Patient education in physiotherapy in total hip arthroplasty (THA) - The perspective of physiotherapists

2018

Background and Purpose There is limited knowledge about patients’ and physiotherapists’ perceptions of patient education in physiotherapy in hip arthroplasty. The aim of this study was to describe physiotherapists’ conceptions of the patient education in physiotherapy needed by patients undergoing total hip arthroplasty. Methods The data for this qualitative study were collected using group and individual semi-structured interviews. Seven physiotherapists were interviewed. The research data were analyzed using a phenomenographic method. Results Three categories of patient education in physiotherapy in hip arthroplasty were produced and the categories formed a hierarchy. The narrowest descri…

AdultMalemusculoskeletal diseaseslonkkaviat030506 rehabilitationmedicine.medical_specialtygenetic structuresAttitude of Health PersonnelArthroplasty Replacement HiptekoniveletPhysical Therapy Sports Therapy and Rehabilitationpatient educationfysioterapia03 medical and health sciences0302 clinical medicinePatient Education as Topichealth services administrationphysiotherapistHumansLearningMedicinehip arthroplastyPhenomenographyfysioterapeutitPhysical Therapy ModalitiesQualitative Researchhealth care economics and organizationsbusiness.industryPerspective (graphical)3. Good healthHip arthroplastypotilasneuvontaPhysical therapyFemalefenomenografia0305 other medical sciencebusinesshuman activities030217 neurology & neurosurgeryTotal hip arthroplastyPatient educationPhysiotherapy Theory and Practice
researchProduct

Mid- to Long-Term Outcome of Cementless Total Hip Arthroplasty in Younger Patients

2010

Purpose. To assess mid- to long-term outcomes of cementless primary total hip arthroplasty (THA) in younger patients. Methods. Records of 28 women and 34 men (75 hips) aged 18 to 55 (mean, 38) years who underwent primary THA using a hydroxyapatite-coated stem and a threaded cup and had been followed up for a mean of 10 (6–15) years were reviewed. 13 of the patients had bilateral THAs. Clinical and radiographic outcomes were evaluated. Results. After a minimum follow-up of 7 (range, 7–14) years, 12 (16%) of the hips were revised, of which 8 (11%) were for the cup. The causes for revision were late deep infections (n=2), aseptic loosening of the cup (n=4), and polyethylene wear (n=6). No stem…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyTime FactorsOsteolysisAdolescentArthroplasty Replacement Hipmedicine.medical_treatmentOsteoarthritisProsthesis DesignOsteoarthritis HipYoung Adultlcsh:Orthopedic surgerymedicineHumansRange of Motion ArticularRetrospective StudiesHip surgerybusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseArthroplastySurgerylcsh:RD701-811Treatment OutcomeHarris Hip ScoreFemaleSurgeryHip ProsthesisbusinessRange of motionFollow-Up StudiesTotal hip arthroplastyJournal of Orthopaedic Surgery
researchProduct

Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins

1991

Plasma lipids and lipoproteins were measured in 21 post-menopausal women after 4 and 8 months of continuous treatment with an orally administered combination of oestradiol and medroxyprogesterone acetate. The mean concentrations of cholesterol and low-density-lipoprotein (LDL) cholesterol were reduced by 12% (P less than 0.001) and 11% (P less than 0.01), respectively, after 4 months of treatment and by 9% (P less than 0.05) and 12% (P less than 0.05) after 8 months. The mean level of high-density-lipoprotein (HDL) cholesterol showed an initial fall of 5% (P less than 0.05) after 4 months and then increased by 13% (P less than 0.05) after 8 months of treatment. The plasma triglycerides leve…

AdultMedroxyprogesteronemedicine.medical_specialtymedicine.drug_classLipoproteinsMedroxyprogesteronemedicine.medical_treatmentGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundInternal medicinePlasma lipidsHumansMedicineMedroxyprogesterone acetateClinical significanceProspective StudiesEstradiolProgestogenbusiness.industryCholesterolEstrogen Replacement TherapyObstetrics and GynecologyMiddle AgedLipidsEndocrinologychemistryEstrogenDrug Therapy CombinationFemalelipids (amino acids peptides and proteins)Menopausebusinessmedicine.drugLipoproteinMaturitas
researchProduct

Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey.

2011

Purpose: To use the Hunter Outcome Survey, an international database, to assess the safety and effectiveness of enzyme replacement therapy with idursulfase in patients with Hunter syndrome who started treatment before 6 years of age. Methods: The study population included all patients enrolled in the Hunter Outcome Survey who started idursulfase infusions (0.5 mg/kg every other week) before 6 years of age and who had at least one follow-up examination recorded. Results: The study population included 124 patients, younger than 6 years, who had a mean age at start of idursulfase of 3.6 ± 1.6 years (mean ± SD). The mean duration of treatment was 22.9 ± 14.6 months. A total of 69 infusion-relat…

AdultPediatricsmedicine.medical_specialtyAdolescentDatabases FactualIdursulfaseUrineIduronate Sulfatasechemistry.chemical_compoundYoung AdultInternational databaseMedicineHumansEnzyme Replacement TherapyYoung adultChildInfusions IntravenousGenetics (clinical)GlycosaminoglycansMucopolysaccharidosis IICreatinineClinical Trials as Topicbusiness.industryData CollectionInfantHunter syndromeEnzyme replacement therapymedicine.diseaseTreatment OutcomechemistryChild PreschoolPopulation studybusinessmedicine.drugGenetics in medicine : official journal of the American College of Medical Genetics
researchProduct

Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double-stranded RNA mimic complexed with polycations in an experim…

2015

Objective To assess the antiproliferative, proapoptotic, and antiangiogenic effects of the double-stranded RNA mimic polyinosine-polycytidylic acid (pIC) complexed with polyethylenimine [pIC PEI ] in xenografted human leiomyomas. Design Heterologous leiomyoma mouse model. Setting University-affiliated infertility center. Animal(s) Ovariectomized and hormone-replaced nude mice (n = 16) who received human leiomyoma fragment transplantation. Intervention(s) Leiomyoma fragments placed in the peritoneum of 5-week-old nude female mice and treated with the vehicle (n = 8) or 0.6 mg/kg [pIC PEI ] (n = 8) for 4 weeks. Main Outcome Measure(s) The size of the leiomyoma implants, and cellular prolifera…

AdultTime FactorsAngiogenesisOvariectomyHeterologousMice NudeAngiogenesis InhibitorsApoptosis03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePeritoneummedicineTumor Cells CulturedAnimalsHumansPolyethyleneimineCell ProliferationPolyethylenimine030219 obstetrics & reproductive medicineLeiomyomaNeovascularization PathologicCell growthbusiness.industryEstrogen Replacement TherapyObstetrics and GynecologyMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysTumor BurdenTransplantationPlatelet Endothelial Cell Adhesion Molecule-1Disease Models AnimalLeiomyomamedicine.anatomical_structureKi-67 AntigenPoly I-CReproductive MedicinechemistryApoptosis030220 oncology & carcinogenesisImmunologyUterine NeoplasmsCancer researchFemalebusinessFertility and sterility
researchProduct

Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.

2009

Hurler-Scheie syndrome is caused by alpha-l-iduronidase deficiency. Enzyme replacement therapy (ERT) can improve physical capacity and reduces organomegaly. However, the effect on bradytrophic connective tissue is limited. As intravenously administered enzyme cannot cross the blood-brain barrier, the therapy of choice for the more severe Hurler syndrome is haematopoietic stem cell transplantation (HCT). In the more attenuated Scheie syndrome, neurological impairment is less severe; therefore, ERT may be appropriate to treat these patients. Information on long-term outcome in Scheie patients undergoing ERT is scarce. We report a 38-year-old female Scheie patient who has been on ERT for 8 yea…

Adultcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyMucopolysaccharidosis IMyelopathyIduronidaseSpinal cord compressionMucopolysaccharidosis IGeneticsmedicineHumansEnzyme Replacement TherapyHurler syndromeGenetics (clinical)business.industryHematopoietic Stem Cell Transplantationnutritional and metabolic diseasesBrainEnzyme replacement therapymedicine.diseaseSpinal cordSurgeryTransplantationmedicine.anatomical_structureCervical VertebraeDisease ProgressionFemaleScheie syndromebusinessSpinal Cord CompressionJournal of inherited metabolic disease
researchProduct

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

2009

Background Hereditary angioedema caused by mutations in the factor XII gene is a recently described disease entity that occurs mainly in women. It differs from hereditary angioedema caused by C1 inhibitor deficiency. Objective To assess the clinical symptoms, factors triggering acute attacks, and treatments of this disease. Methods Thirty-five female patients with hereditary angioedema and the factor XII mutations p.Thr309Lys and p.Thr309Arg who came from 13 unrelated families were studied. The observation period was 8.4 years on average (range, 2-26 years). Results Patients had on average 12.7 ± 7.9 angioedema attacks per year. Recurrent facial swellings occurred in all patients; skin swel…

Adultmedicine.medical_specialtyAbdominal painAdolescentmedicine.medical_treatmentImmunologyMutation MissenseSeverity of Illness IndexC1-inhibitorYoung AdultRisk FactorsSurveys and QuestionnairesImmunology and AllergyMedicineHumansHereditary Angioedema Type IIIAge of OnsetChildProgesteroneDanazolPregnancyAngioedemabiologybusiness.industryDanazolAngioedemas HereditaryHormone replacement therapy (menopause)Middle Agedmedicine.diseaseDermatologySurgeryPedigreeTranexamic AcidHereditary angioedemaFactor XIIbiology.proteinFemalemedicine.symptombusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct